Jennifer Doan

Array ( [id] => 1566777 [patent_doc_number] => 06376495 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them' [patent_app_type] => B1 [patent_app_number] => 09/744693 [patent_app_country] => US [patent_app_date] => 2001-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5333 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376495.pdf [firstpage_image] =>[orig_patent_app_number] => 09744693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4326686 [patent_doc_number] => 06329370 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Phthalazine derivatives phosphodiesterase 4 inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/743813 [patent_app_country] => US [patent_app_date] => 2001-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32194 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329370.pdf [firstpage_image] =>[orig_patent_app_number] => 743813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433394 [patent_doc_number] => 06340684 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Phthalazine derivatives as phosphodiesterase 4 inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/764983 [patent_app_country] => US [patent_app_date] => 2001-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10164 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340684.pdf [firstpage_image] =>[orig_patent_app_number] => 09764983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6511353 [patent_doc_number] => 20020025962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof' [patent_app_type] => new [patent_app_number] => 09/765515 [patent_app_country] => US [patent_app_date] => 2001-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9650 [patent_no_of_claims] => 120 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20020025962.pdf [firstpage_image] =>[orig_patent_app_number] => 09765515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936692 [patent_doc_number] => 20020061892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Antiviral azaindole derivatives' [patent_app_type] => new [patent_app_number] => 09/765189 [patent_app_country] => US [patent_app_date] => 2001-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26641 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061892.pdf [firstpage_image] =>[orig_patent_app_number] => 09765189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7041278 [patent_doc_number] => 20010005753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-28 [patent_title] => '6-(4-arylalkylpiperazin-1-yl) benzodioxane and 6-(4-arylalkylpiperazin-1-yl) chromane derivatives: dopamine receptor subtype specific ligands' [patent_app_type] => new-utility [patent_app_number] => 09/761048 [patent_app_country] => US [patent_app_date] => 2001-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5179 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20010005753.pdf [firstpage_image] =>[orig_patent_app_number] => 09761048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6892277 [patent_doc_number] => 20010018439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Polyhydroxyalkylpyrazine derivatives and their preparation and medicines containing them' [patent_app_type] => new [patent_app_number] => 09/758409 [patent_app_country] => US [patent_app_date] => 2001-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4159 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018439.pdf [firstpage_image] =>[orig_patent_app_number] => 09758409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7079039 [patent_doc_number] => 20010041691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'Water soluble prodrugs of azole compounds' [patent_app_type] => new [patent_app_number] => 09/757438 [patent_app_country] => US [patent_app_date] => 2001-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5534 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041691.pdf [firstpage_image] =>[orig_patent_app_number] => 09757438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477967 [patent_doc_number] => 06344456 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Piperazinone derivatives and their uses' [patent_app_type] => B1 [patent_app_number] => 09/743411 [patent_app_country] => US [patent_app_date] => 2001-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8927 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344456.pdf [firstpage_image] =>[orig_patent_app_number] => 09743411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1441215 [patent_doc_number] => 06335337 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-01 [patent_title] => 'Substituted piperazinones and their therapeutic uses' [patent_app_type] => B1 [patent_app_number] => 09/743352 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11298 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 333 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/335/06335337.pdf [firstpage_image] =>[orig_patent_app_number] => 09743352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586151 [patent_doc_number] => 06358958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-03-19 [patent_title] => 'Arylpiperazines having activity at the serotonin 1A receptor' [patent_app_type] => B2 [patent_app_number] => 09/753645 [patent_app_country] => US [patent_app_date] => 2001-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17587 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358958.pdf [firstpage_image] =>[orig_patent_app_number] => 09753645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640176 [patent_doc_number] => 06395739 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'N-phenyl-N-phenylpopylpiperazine derivatives and process for the preparation' [patent_app_type] => B1 [patent_app_number] => 09/720781 [patent_app_country] => US [patent_app_date] => 2000-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4903 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395739.pdf [firstpage_image] =>[orig_patent_app_number] => 09720781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416379 [patent_doc_number] => 06521621 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => '1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives' [patent_app_type] => B1 [patent_app_number] => 09/745513 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18984 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 810 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521621.pdf [firstpage_image] =>[orig_patent_app_number] => 09745513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347157 [patent_doc_number] => 20040192695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Method for producing 4-(heteroaryl-methyl)-halogen-1(2h)-phthalazinones' [patent_app_type] => new [patent_app_number] => 10/168794 [patent_app_country] => US [patent_app_date] => 2003-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1223 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192695.pdf [firstpage_image] =>[orig_patent_app_number] => 10168794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6885116 [patent_doc_number] => 20010039280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-08 [patent_title] => 'Optically active 3-[(2-Piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT 1D receptor selective antagonists' [patent_app_type] => new [patent_app_number] => 09/740361 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11594 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20010039280.pdf [firstpage_image] =>[orig_patent_app_number] => 09740361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6822162 [patent_doc_number] => 20030220323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Alpha-arylethylpiperazine derivatives as neurokinin antagonists' [patent_app_type] => new [patent_app_number] => 10/168331 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32935 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220323.pdf [firstpage_image] =>[orig_patent_app_number] => 10168331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459111 [patent_doc_number] => 06426347 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-07-30 [patent_title] => '1-phenyl-4-benzylpiperazines dopamine receptor subtype specific ligands' [patent_app_type] => B2 [patent_app_number] => 09/736566 [patent_app_country] => US [patent_app_date] => 2000-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3462 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/426/06426347.pdf [firstpage_image] =>[orig_patent_app_number] => 09736566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1600729 [patent_doc_number] => 06475955 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-11-05 [patent_title] => 'Pyridazinone derivatives' [patent_app_type] => B2 [patent_app_number] => 09/732901 [patent_app_country] => US [patent_app_date] => 2000-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15903 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1737 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475955.pdf [firstpage_image] =>[orig_patent_app_number] => 09732901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6451153 [patent_doc_number] => 20020177598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-28 [patent_title] => 'Piperazine derivatives and their use as anti-inflammatory agents' [patent_app_type] => new [patent_app_number] => 09/726808 [patent_app_country] => US [patent_app_date] => 2000-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80296 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20020177598.pdf [firstpage_image] =>[orig_patent_app_number] => 09726808 [rel_patent_id] =>[rel_patent_doc_number] =>)